GE HealthCare Technologies Inc. (GEHC)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $37.54B
Last updated: Nov 17, 2026 at 11:06 AM ET
GE HealthCare Technologies Inc. (GEHC) Financials: Revenue, Profit and Cash Flow
GE HealthCare Technologies reported revenue of $20.63B for the fiscal year ended Dec 31, 2025, up 4.8% from the year before. That year, net income was $2.15B with a net margin of 10.4%, operating cash flow was $1.99B and free cash flow was $1.50B. The quarter ended Sep 30, 2026 had revenue of $5.51B and net income of $623.00M.
Revenue and Margins
The operating margin was 13.4% in the fiscal year ended Dec 2025. Over the 6 years to Dec 2025, revenue grew from $16.63B, a compound annual rate of 3.7%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $20.63B | +4.8% | 40.0% | 13.4% | 10.4% |
| Dec 2024 | $19.67B | +0.6% | 41.7% | 13.3% | 10.4% |
| Dec 2023 | $19.55B | +6.6% | 40.5% | 12.5% | 8.3% |
| Dec 2022 | $18.34B | +4.3% | 39.1% | 13.8% | 10.7% |
| Dec 2021 | $17.59B | +2.5% | 40.8% | 15.9% | 13.0% |
| Dec 2020 | $17.16B | +3.2% | 39.4% | 15.8% | 80.7% |
| Dec 2019 | $16.63B | N/A | 39.4% | 12.8% | 9.2% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 4.9% from the year before. In the quarter ended Sep 2026, net income rose 34.3% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $20.63B | $19.67B | $19.55B | $18.34B | $17.59B | $17.16B | $16.63B |
| Cost of revenue | $12.38B | $11.47B | $11.63B | $11.16B | $10.41B | $10.40B | $10.09B |
| Gross profit | $8.25B | $8.21B | $7.92B | $7.18B | $7.17B | $6.77B | $6.55B |
| Research and development | $1.26B | $1.31B | $1.21B | $1.03B | $816.00M | $810.00M | $833.00M |
| Operating income | $2.76B | $2.63B | $2.44B | $2.52B | $2.79B | $2.72B | $2.12B |
| Net income | $2.15B | $2.05B | $1.61B | $1.97B | $2.29B | $13.85B | $1.52B |
| EBITDA | $3.79B | $3.67B | $3.51B | $3.22B | $3.54B | $3.41B | $2.84B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.51B | $5.29B | $5.13B | $5.70B | $5.14B | $5.01B | $4.78B | $5.32B | $4.86B | $4.84B | $4.65B | $5.21B |
| Gross profit | $2.22B | $2.18B | $1.98B | $2.26B | $1.99B | $1.99B | $2.01B | $2.27B | $2.03B | $2.00B | $1.90B | $2.16B |
| Operating income | $805.00M | $739.00M | $515.00M | $827.00M | $653.00M | $654.00M | $629.00M | $801.00M | $676.00M | $608.00M | $540.00M | $689.00M |
| Net income | $623.00M | $573.00M | $411.00M | $602.00M | $464.00M | $500.00M | $588.00M | $737.00M | $490.00M | $435.00M | $388.00M | $416.00M |
Balance Sheet
As of Dec 2025, total debt of $10.00B exceeded cash and equivalents by $5.49B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
| Total assets | $36.91B | $33.09B | $32.45B | $27.54B | $26.31B | $24.23B | N/A |
| Current assets | $12.50B | $9.90B | $9.41B | $8.32B | $6.54B | $5.45B | N/A |
| Cash and equivalents | $4.51B | $2.89B | $2.50B | $1.45B | $556.00M | $1.01B | N/A |
| Total liabilities | $26.31B | $24.44B | $25.14B | $17.95B | $9.41B | $9.25B | N/A |
| Short-term debt | $508.00M | $1.50B | $1.01B | $15.00M | $110.00M | $132.00M | N/A |
| Long-term debt | $9.49B | $7.45B | $8.44B | $8.23B | $31.00M | $31.00M | N/A |
| Shareholder equity | $10.38B | $8.45B | $7.13B | $9.36B | $16.66B | $14.73B | N/A |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $38.37B | $37.25B | $37.13B | $36.91B | $36.13B | $35.50B | $33.59B | $33.09B | $33.85B | $31.85B | $32.21B | $32.45B |
| Total liabilities | $26.51B | $26.03B | $26.23B | $26.31B | $25.91B | $25.55B | $24.17B | $24.44B | $25.34B | $23.86B | $24.61B | $25.14B |
| Cash and equivalents | $2.85B | $2.10B | $2.29B | $4.51B | $4.03B | $3.76B | $2.47B | $2.89B | $3.57B | $2.02B | $2.56B | $2.50B |
| Shareholder equity | $11.61B | $10.97B | $10.67B | $10.38B | $9.99B | $9.71B | $9.19B | $8.45B | $8.32B | $7.80B | $7.41B | $7.13B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 75.4% of operating cash flow. Dividends and share repurchases together came to 17.6% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.99B | $1.95B | $2.10B | $2.11B | $1.61B | $1.69B | $1.99B |
| Capital expenditures | $482.00M | $401.00M | $387.00M | $310.00M | $248.00M | $259.00M | $331.00M |
| Free cash flow | $1.50B | $1.55B | $1.71B | $1.80B | $1.36B | $1.43B | $1.66B |
| Dividends paid | $64.00M | $55.00M | $41.00M | $0 | $0 | N/A | N/A |
| Share repurchases | $200.00M | $0 | $211.00M | $0 | $0 | N/A | N/A |
| Investing cash flow | -$1.05B | -$914.00M | -$558.00M | -$398.00M | -$1.76B | $19.99B | -$325.00M |
| Financing cash flow | $617.00M | -$573.00M | -$478.00M | -$822.00M | -$263.00M | -$21.54B | -$1.57B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $907.00M | $168.00M | $290.00M | $1.05B | $593.00M | $94.00M | $250.00M | $913.00M | $738.00M | -$119.00M | $419.00M | $1.05B |
| Capital expenditures | $114.00M | $100.00M | $178.00M | $134.00M | $110.00M | $86.00M | $152.00M | $102.00M | $90.00M | $64.00M | $145.00M | $94.00M |
| Free cash flow | $793.00M | $68.00M | $112.00M | $916.00M | $483.00M | $8.00M | $98.00M | $811.00M | $648.00M | -$183.00M | $274.00M | $956.00M |
Frequently Asked Questions About GEHC
What is GE HealthCare Technologies' annual revenue?
GE HealthCare Technologies reported revenue of $20.63B for the fiscal year ended Dec 31, 2025.
How fast is GE HealthCare Technologies' revenue growing?
Revenue was up 4.8% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 4.0%.
Is GE HealthCare Technologies profitable?
Yes. GE HealthCare Technologies reported net income of $2.15B for the fiscal year ended Dec 31, 2025, with a net margin of 10.4%.
How much free cash flow does GEHC generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $1.99B minus capital expenditures of $482.00M produced free cash flow of $1.50B.
How much debt does GE HealthCare Technologies have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $9.49B, short-term debt of $508.00M and cash and equivalents of $4.51B.
GEHC pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors